IDH1 and central nervous system cancer: A recent study2 comprising lower-grade gliomas and glioblastomas hinted at a finer classification of these tumors, finding a CIMP-low subgroup of IDH mutant non-codel tumors, with lower methylation and worse survival than the rest of the non-codel group.